Sign In
Buy INSM
$103.86
+0.130 (+0.125%)
At Close: Jun 03, 2026
Insmed: "Strong Buy" As Possible Label Expansion For ARIKAYCE Bodes Well
05:10pm, Tuesday, 24'th Mar 2026
Insmed (INSM) remains a "Strong Buy", driven by positive phase 3b ENCORE results for ARIKAYCE in 1st-line MAC lung disease and robust pipeline progress. INSM is positioned to expand ARIKAYCE's label t
INSM Stock Gains After Arikayce Hits Goal in Label Expansion Study
10:10am, Tuesday, 24'th Mar 2026
Insmed stock jumps as Arikayce meets key goals in a late-stage study, paving the way for label expansion and a major boost to its potential market.
Insmed Incorporated (INSM) Shareholder/Analyst Call Transcript
12:43pm, Monday, 23'rd Mar 2026
Insmed Incorporated (INSM) Shareholder/Analyst Call Transcript
Insmed Lung Infection Therapy Data Impresses, Analyst Sees Approval Path
12:24pm, Monday, 23'rd Mar 2026
The ENCORE study's results indicate that Arikayce (amikacin liposome inhalation suspension), in combination with a multidrug therapy, met its primary and all secondary endpoints, showcasing its potent
Insmed shares rise on positive late-stage trial results for lung disease therapy
10:12am, Monday, 23'rd Mar 2026
Insmed Incorporated (NASDAQ:INSM) shares jumped almost 8% in early trade on Monday after the company reported positive topline results from a Phase 3b study evaluating its lung disease therapy ARIKAY
—The Study Met Primary and All Multiplicity-Controlled Secondary Culture Conversion Endpoints, Demonstrating Statistically Significant and Clinically Meaningful Improvements in Respiratory Symptom S
506,245 Shares in Insmed, Inc. $INSM Bought by Bank of Nova Scotia
04:30am, Monday, 16'th Mar 2026
Bank of Nova Scotia purchased a new stake in shares of Insmed, Inc. (NASDAQ: INSM) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchang
Aquatic Capital Management LLC Has $10.99 Million Stake in Insmed, Inc. $INSM
03:29am, Monday, 16'th Mar 2026
Aquatic Capital Management LLC trimmed its stake in Insmed, Inc. (NASDAQ: INSM) by 61.8% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC)
Algert Global LLC Purchases 62,802 Shares of Insmed, Inc. $INSM
03:27am, Sunday, 15'th Mar 2026
Algert Global LLC boosted its position in shares of Insmed, Inc. (NASDAQ: INSM) by 76.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
Insmed Incorporated (INSM) Presents at Leerink Global Healthcare Conference 2026 Transcript
11:00am, Tuesday, 10'th Mar 2026
Insmed Incorporated (INSM) Presents at Leerink Global Healthcare Conference 2026 Transcript
Insider Selling: Insmed (NASDAQ:INSM) CEO Sells $1,562,374.97 in Stock
04:52am, Sunday, 08'th Mar 2026
Insmed, Inc. (NASDAQ: INSM - Get Free Report) CEO William Lewis sold 10,699 shares of the company's stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $146.03, fo
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
07:00am, Thursday, 05'th Mar 2026
BRIDGEWATER, N.J., March 5, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transfor
Baron Health Care Fund Q4 2025 Contributors And Detractors
10:18am, Tuesday, 03'rd Mar 2026
Eli Lilly and Company's shares rose during the quarter as Zepbound's obesity launch continued to gain strong traction. Cidara Therapeutics' shares rose further following Merck's acquisition of the com
Insmed Incorporated (INSM) Presents at TD Cowen 46th Annual Health Care Conference Transcript
12:17pm, Monday, 02'nd Mar 2026
Insmed Incorporated (INSM) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Artisan Partners Limited Partnership Grows Stock Position in Insmed, Inc. $INSM
03:16am, Friday, 27'th Feb 2026
Artisan Partners Limited Partnership grew its position in shares of Insmed, Inc. (NASDAQ: INSM) by 49.0% during the third quarter, according to its most recent disclosure with the Securities and Excha
